Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 1/20 | 0.49 |
| ▸ | SIRT3 | Q9NTG7 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | CCNC | P24863 | 2/20 | 0.33 |
| ▸ | CDK8 | P49336 | 2/20 | 0.33 |
| ▸ | MPI | P34949 | 1/20 | 0.32 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25752582 | 0.84 | MPI (0.41) | TRPA1SIRT3TDP1CCNCCDK8 | |
| SCHEMBL23127915 | 0.82 | TRPA1 (0.50) | TRPA1SIRT3TDP1MPICYP2A6 | |
| SCHEMBL20613222 | 0.77 | TRPA1 (0.46) | TRPA1SIRT3TDP1MPI | |
| SCHEMBL22787372 | 0.77 | TRPA1 (0.46) | TRPA1SIRT3TDP1MPI | |
| SCHEMBL16187302 | 0.76 | ALDH1A1 (0.41) | TDP1 | |
| SCHEMBL28182992 | 0.74 | TRPA1 (0.56) | TRPA1 | |
| SCHEMBL6270080 | 0.72 | — | — | |
| SCHEMBL25752567 | 0.70 | CYP2C9 (0.55) | TDP1MPI | |
| SCHEMBL19049163 | 0.69 | TRPA1 (0.50) | TRPA1SIRT3TDP1CCNCCDK8 | |
| SCHEMBL7116943 | 0.68 | TRPA1 (0.49) | TRPA1SIRT3TDP1CCNCCDK8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230197361-A1 | CONDUCTIVE TWO-DIMENSIONAL (2D) COVALENT ORGANIC FRAMEWORKS (COFS) AND METHOD OF MAKING AN ELECTRODE MATERIAL | UNIV KING ABDULLAH SCI & TECH (SA) | 2023-06-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230197361-A1 | CONDUCTIVE TWO-DIMENSIONAL (2D) COVALENT ORGANIC FRAMEWORKS (COFS) AND METHOD OF MAKING AN ELECTRODE MATERIAL | TET3, TET1, ALKBH2 | TRPA1 613/4885SIRT3 940/4885TDP1 2631/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.